CoverorDie

Squeeze Report — September 30, 2026

The tape splits into two crowded trades: high-days-to-cover biotechs waiting on November earnings (HALO, TNGX, SRPT) and heavily shorted names where borrow is cheap and shorts aren't stressed. The interesting setups are the ones where a hard catalyst meets a real fundamental edge — HALO's buyback-plus-guidance-raise and SGRY's completed divestiture stand out.

15 ranked3 hot (≥80)15 squeezable (≥73)

Today's top short-squeeze candidates

  1. #1ORICOric Pharmaceuticals, Inc. Com83

    36% of float sold short · 14.2 days to cover · +3% over 20 days

    SI 36%DTC 14.2$13.37+3% 20dHealthcare
  2. #2GRPNGroupon, Inc. Common Stock81

    65% of float sold short · 14.3 days to cover · +4% over 20 days

    SI 65%DTC 14.3$19.99+4% 20dCommunication Services
  3. #3TNGXTango Therapeutics, Inc.80

    39.4% short interest and 18.8 days-to-cover are tinder, but a $690M June offering and zero approved products cap the upside.

    SI 39%DTC 18.8$24.42+7% 20dHealthcare
  4. #4ABSIAbsci Corporation Common Stock80

    25% of float sold short · 14.4 days to cover · +12% over 20 days

    SI 25%DTC 14.4$10.14+12% 20dHealthcare
  5. #5ACHCAcadia Healthcare Company, Inc77

    24.9% short interest and 18.8 DTC look juicy, but DOJ/SEC investigations and bearish options skew overwhelm the setup into Nov 4.

    SI 25%DTC 18.8$28.04+2% 20dHealthcare
  6. #6PGENPrecigen, Inc. Common Stock77

    52-week high and FDA Platform Designation meet $38.7M cash against $93.9M secured debt — Q3 Papzimeos uptake is the binary.

    SI 27%DTC 16.3$8.05+16% 20dHealthcare
  7. #7PRCHPorch Group, Inc. Common Stock77

    19.6% short interest and 12.9 DTC are live, but negative equity and 4.3% ATM IV suggest the options market sees no squeeze.

    SI 20%DTC 12.9$16.57-2% 20dFinancial Services
  8. #8SEISolaris Energy Infrastructure,77

    36% of float sold short · 5.1 days to cover · +35% over 20 days

    SI 36%DTC 5.1$68.34+35% 20dEnergy
  9. #9NTLAIntellia Therapeutics, Inc. Co76

    34.9% short interest and cheap options could amplify an upside surprise, but 12.7% float expansion and liver-toxicity overhang kill the bull case.

    SI 35%DTC 14.1$12.03-5% 20dHealthcare
  10. #10VOYGVoyager Technologies, Inc.76

    20% of float sold short · 8.7 days to cover · -9% over 20 days

    SI 20%DTC 8.7$30.74-9% 20dIndustrials
  11. #11NEONeoGenomics, Inc. Common Stock76

    72% of float sold short · 11.2 days to cover · +5% over 20 days

    SI 72%DTC 11.2$18.74+5% 20dHealthcare
  12. #12CRSPCRISPR Therapeutics AG Common75

    20% of float sold short · 16.5 days to cover · -2% over 20 days

    SI 20%DTC 16.5$56.00-2% 20dHealthcare
  13. #13KODKodiak Sciences Inc Common Sto75

    18% of float sold short · 17.9 days to cover · +144% over 20 days

    SI 18%DTC 17.9$91.12+144% 20dHealthcare
  14. #14SMMTSummit Therapeutics Inc. Commo75

    37% of float sold short · 6.6 days to cover · +20% over 20 days

    SI 37%DTC 6.6$16.39+20% 20dHealthcare
  15. #15IBRXImmunityBio, Inc. Common Stock75

    110% of float sold short · 15.9 days to cover · +11% over 20 days

    SI 110%DTC 15.9$8.83+11% 20dHealthcare

See the full ranked board

This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.

Open the live squeeze board →